The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Dissecting the genomic complexity underlying medulloblastoma
Open accessAbstract
Medulloblastoma is the most common brain tumour in children; using whole-genome sequencing of tumour samples the authors show that the clinically challenging Group 3 and 4 tumours can be tetraploid, and reveal the expression of the first medulloblastoma fusion genes identified. Medulloblastoma is the most common malignant brain tumour in children. Four papers published in the 2 August 2012 issue of Nature use whole-genome and other sequencing techniques to produce a detailed picture of the genetics and genomics of this condition. Notable findings include the identification of recurrent mutations in genes not previously implicated in medulloblastoma, with significant genetic differences associated with the four biologically distinct subgroups and clinical outcomes in each. Potential avenues for therapy are suggested by the identification of targetable somatic copy-number alterations, including recurrent events targeting TGFβ signalling in Group 3, and NF-κB signalling in Group 4 medulloblastomas. Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity1. Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles are currently identified2,3. WNT tumours, showing activated wingless pathway signalling, carry a favourable prognosis under current treatment regimens4. SHH tumours show hedgehog pathway activation, and have an intermediate prognosis2. Group 3 and 4 tumours are molecularly less well characterized, and also present the greatest clinical challenges2,3,5. The full repertoire of genetic events driving this distinction, however, remains unclear. Here we describe an integrative deep-sequencing analysis of 125 tumour–normal pairs, conducted as part of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project. Tetraploidy was identified as a frequent early event in Group 3 and 4 tumours, and a positive correlation between patient age and mutation rate was observed. Several recurrent mutations were identified, both in known medulloblastoma-related genes (CTNNB1, PTCH1, MLL2, SMARCA4) and in genes not previously linked to this tumour (DDX3X, CTDNEP1, KDM6A, TBR1), often in subgroup-specific patterns. RNA sequencing confirmed these alterations, and revealed the expression of what are, to our knowledge, the first medulloblastoma fusion genes identified. Chromatin modifiers were frequently altered across all subgroups. These findings enhance our understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provide several potential targets for new therapeutics, especially for Group 3 and 4 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Self-citationThe Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C. L., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,541
Self-citationMassive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936
Self-citationMedulloblastoma Comprises Four Distinct Molecular Variants
Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S. C., Bouffet, É., Clifford, S. C., Hawkins, C. E., French, P. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,353
Self-citationEnglund, C., Fink, A., Lau, C., Pham, D., Daza, R. A. M., Bulfone, A., Kowalczyk, T., & Hevner, R. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2899-04.2005 · Cited by 1,261
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C. L., Stevenson, K. E., Werner, L. L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,103
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D., Schlanstein, M., Northcott, P. A., Cho, Y., Köster, J., Meeteren, A. Y. N. S., van Vuurden, D. G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,057
Self-citationRausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Self-citation
Flagged first, then by citations
2 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 852
MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer
Sze, C. C., & Shilatifard, A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026427 · Cited by 164
The cancer COMPASS: navigating the functions of MLL complexes in cancer
Ford, D. J., & Dingwall, A. K. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.01.005 · Cited by 169
Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities
Pierre, R. S., & Kadoch, C. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.004 · Cited by 165
Weinreb, I., Zhang, L., Tirunagari, L. M., Sung, Y., Chen, C., Perez‐Ordoñez, B., Clarke, B. A., Skálová, A., Chiosea, S. I., Seethala, R. R., et al. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22195 · Cited by 160
The evolution of the TOR pathway and its role in cancer
Beauchamp, E. M., & Platanias, L. C. (2012) · Oncogene · doi:10.1038/onc.2012.567 · Cited by 158
Gallo, L. H., Nelson, K. N., Meyer, A. N., & Donoghue, D. J. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.03.003 · Cited by 155
Massimino, M., Biassoni, V., Gandola, L., Garrè, M. L., Gatta, G., Giangaspero, F., Poggi, G., & Rutkowski, S. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.05.012 · Cited by 152
Self-citationPathology, diagnostics, and classification of medulloblastoma
Orr, B. A. (2020) · Brain Pathology · doi:10.1111/bpa.12837 · Cited by 169
Cheng, W., Wang, S., Zhang, Z., Morgens, D. W., Hayes, L. R., Lee, S., Portz, B., Xie, Y., Nguyen, B. V., Haney, M. S., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.003 · Cited by 138
The Cancer Cell Map Initiative: Defining the Hallmark Networks of Cancer
Krogan, N. J., Lippman, S. M., Agard, D. A., Ashworth, A., & Ideker, T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.008 · Cited by 154
The H3K27me3 demethylase UTX in normal development and disease
der Meulen, J. V., Speleman, F., & Vlierberghe, P. V. (2014) · Epigenetics · doi:10.4161/epi.28298 · Cited by 150
McCubrey, J. A., Rakus, D., Gizak, A., Steelman, L. S., Abrams, S. L., Lertpiriyapong, K., Fitzgerald, T. L., Yang, L. V., Montalto, G., Cervello, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.004 · Cited by 152
Genetic landscape of meningioma
Yuzawa, S., Nishihara, H., & Tanaka, S. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0271-7 · Cited by 149
Pietsch, T., Schmidt, R., Remke, M., Korshunov, A., Hovestadt, V., Jones, D., Felsberg, J., Kaulich, K., Goschzik, T., Kool, M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1276-0 · Cited by 148
Self-citationLulla, R. R., Goldman, S., Yamada, T., Beattie, C. W., Bressler, L. R., Pacini, M., Pollack, I. F., Fisher, P. G., Packer, R. J., Dunkel, I. J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now047 · Cited by 148
Molecular Insights into Pediatric Brain Tumors Have the Potential to Transform Therapy
Gajjar, A. J., Pfister, S. M., Taylor, M. D., & Gilbertson, R. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0833 · Cited by 150
Self-citationThe molecular landscape of ETMR at diagnosis and relapse
Lambo, S., Gröbner, S. N., Rausch, T., Waszak, S. M., Schmidt, C., Gorthi, A., Romero, J. C., Mauermann, M., Brabetz, S., Krausert, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1815-x · Cited by 151
Self-citationA cell‐based model system links chromothripsis with hyperploidy
Mardin, B. R., Drainas, A. P., Waszak, S. M., Weischenfeldt, J., Isokane, M., Stütz, A. M., Raeder, B., Efthymiopoulos, T., Buccitelli, C., Segura‐Wang, M., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156505 · Cited by 144
Self-citationAurora kinase A, a synthetic lethal target for precision cancer medicine
Mou, P. K., Yang, E. J., Shi, C., Ren, G., Tao, S., & Shim, J. S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00635-6 · Cited by 150
DDX3, a potential target for cancer treatment
Bol, G. M., Xie, M., & Raman, V. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0461-7 · Cited by 142
Landscape of Genomic Alterations in Pituitary Adenomas
Bi, W. L., Horowitz, P. M., Greenwald, N. F., Abedalthagafi, M., Agarwalla, P. K., Gibson, W. J., Mei, Y., Schumacher, S. E., Ben‐David, U., Chevalier, A. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0790 · Cited by 146
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer
Qu, Y., Olsen, J. R., Xing, Y., Cheng, P. F., Levesque, M. P., Brokstad, K. A., Hoffman, P. S., Oyan, A. M., Zhang, W., Kalland, K., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2510 · Cited by 143
Ezponda, T., Dupéré-Richer, D., Will, C., Small, E. C., Varghese, N., Patel, T., Nabet, B., Popovic, R., Oyer, J. A., Bulic, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.078 · Cited by 141
Béchet, D., Gielen, G. H., Korshunov, A., Pfister, S. M., Rousso, C., Faury, D., Fiset, P., Benlimame, N., Lewis, P. W., Lü, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1337-4 · Cited by 139
Self-citationPark, D. H., Hong, S. J., Salinas, R. D., Liu, S. J., Sun, S. W., Sgualdino, J., Testa, G., Matzuk, M. M., Iwamori, N., & Lim, D. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.060 · Cited by 139
Inactivating CUX1 mutations promote tumorigenesis
Wong, C. C., Martin, S., Rust, A. G., Rashid, M., Alifrangis, C., Alexandrov, L. B., Tiffen, J. C., Kober, C., Green, A. R., Massie, C. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2846 · Cited by 135
Ishaque, N., Abba, M. L., Hauser, C., Patil, N., Paramasivam, N., Huebschmann, D., Leupold, J. H., Balasubramanian, G. P., Kleinheinz, K., Toprak, U. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07041-z · Cited by 132
Self-citationKMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation
Guo, C., Chen, L. H., Huang, Y., Chang, C., Wang, P., Pirozzi, C. J., Qin, X., Bao, X., Greer, P. K., McLendon, R. E., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1555 · Cited by 136
Chen, H.-H., Yu, H.-I., Cho, W.-C., & Tarn, W.-Y. (2014) · Oncogene · doi:10.1038/onc.2014.190 · Cited by 129
Genomic landscape of intracranial meningiomas
Bi, W. L., Abedalthagafi, M., Horowitz, P. M., Agarwalla, P. K., Mei, Y., Aizer, A. A., Brewster, R., Dunn, G. P., Al‐Mefty, O., Alexander, B. M., et al. (2016) · Journal of neurosurgery · doi:10.3171/2015.6.jns15591 · Cited by 131
Cohesin mutations in human cancer
Hill, V. K., Kim, J.-S., & Waldman, T. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.05.002 · Cited by 137
Casein kinase 1 and Wnt/β-catenin signaling
Cruciat, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.08.003 · Cited by 139
Subgroup-specific immune and stromal microenvironment in medulloblastoma
Bockmayr, M., Mohme, M., Klauschen, F., Winkler, B., Budczies, J., Rutkowski, S., & Schüller, U. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1462430 · Cited by 121
Self-citationUnderstanding mutagenesis through delineation of mutational signatures in human cancer
Petljak, M., & Alexandrov, L. B. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw055 · Cited by 110
TelomereHunter – in silico estimation of telomere content and composition from cancer genomes
Feuerbach, L., Sieverling, L., Deeg, K. I., Ginsbach, P., Hutter, B., Buchhalter, I., Northcott, P. A., Mughal, S. S., Chudasama, P., Glimm, H., et al. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2851-0 · Cited by 120
Self-citationShinsky, S. A., Monteith, K. E., Viggiano, S. C., & Cosgrove, M. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627646 · Cited by 118
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., & Jerónimo, C. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00427 · Cited by 125
Jo, V. Y., Sholl, L. M., & Krane, J. F. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000669 · Cited by 122
Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies
Wang, J., Garancher, A., Ramaswamy, V., & Wechsler-Reya, R. J. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-013838 · Cited by 113
Nikiforova, M. N., Wald, A. I., Melan, M. A., Roy, S., Zhong, S., Hamilton, R. L., Lieberman, F. S., Drappatz, J., Amankulor, N., Pollack, I. F., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov289 · Cited by 121
H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model
Haag, D., Mack, N. L., da Silva, P. B. G., Statz, B., Clark, J., Tanabe, K., Sharma, T., Jäger, N., Jones, D., Kawauchi, D., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.005 · Cited by 127
Self-citationEpigenomic regulation of oncogenesis by chromatin remodeling
Kumar, R., Li, D.-Q., Müller, S., & Knapp, S. (2016) · Oncogene · doi:10.1038/onc.2015.513 · Cited by 117
Chang, W., Brohl, A. S., Patidar, R., Sindiri, S., Shern, J. F., Wei, J. S., Song, Y., Yohe, M. E., Gryder, B. E., Zhang, S., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2717 · Cited by 117
DDX3 depletion represses translation of mRNAs with complex 5′ UTRs
Calviello, L., Venkataramanan, S., Rogowski, K. J., Wyler, E., Wilkins, K., Tejura, M., Thai, B., Krol, J., Filipowicz, W., Landthaler, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab287 · Cited by 114
Oncogenes and tumor suppressor genes: functions and roles in cancers
Dakal, T. C., Dhabhai, B., Pant, A., Moar, K., Chaudhary, K., Yadav, V., Ranga, V., Sharma, N. K., Kumar, A., Maurya, P. K., et al. (2024) · MedComm · doi:10.1002/mco2.582 · Cited by 139
Cai, H., Kumar, N., Bagheri, H. C., von Mering, C., Robinson, M. D., & Baudis, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-82 · Cited by 111
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Cai, W., Chen, Z. X., Rane, G., Singh, S. S., Choo, Z., Wang, C., Yuan, Y., Tan, T. Z., Arfuso, F., Yap, C. T., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw278 · Cited by 116
Goschzik, T., Schwalbe, E. C., Hicks, D., Smith, A. J., Muehlen, A. Z., Figarella-Branger, D. F., Doz, F., Rutkowski, S., Lannering, B., Pietsch, T., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30532-1 · Cited by 113
Self-citationEnhancer deregulation in cancer and other diseases
Herz, H. (2016) · BioEssays · doi:10.1002/bies.201600106 · Cited by 110
Gottardo, N. G., Hansford, J. R., McGlade, J. P., Alvaro, F., Ashley, D. M., Bailey, S., Baker, D. L., Bourdeaut, F., Cho, Y., Clay, M. A., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1213-7 · Cited by 110
Self-citationStrategies to target the Hedgehog signaling pathway for cancer therapy
Xin, M., Ji, X., Cruz, L. K. D. L., Thareja, S., & Wang, B. (2018) · Medicinal Research Reviews · doi:10.1002/med.21482 · Cited by 108
Rugo, H. S., Jacobs, I. A., Sharma, S., Scappaticci, F. A., Paul, T. A., Jensen-Pergakes, K., & Malouf, G. G. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01379-x · Cited by 109
Shi, X., Zhang, Z., Zhan, X., Cao, M., Satoh, T., Akira, S., Shpargel, K. B., Magnuson, T., Li, Q., Wang, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms6425 · Cited by 106
Gu, B., & Lee, M. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-39 · Cited by 113
An epigenetic gateway to brain tumor cell identity
Mack, S. C., Hubert, C. G., Miller, T. E., Taylor, M. D., & Rich, J. N. (2015) · Nature Neuroscience · doi:10.1038/nn.4190 · Cited by 106
Self-citationEndris, V., Buchhalter, I., Allgäuer, M., Rempel, E., Lier, A., Volckmar, A., Kirchner, M., von Winterfeld, M., Leichsenring, J., Neumann, O., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32002 · Cited by 107
Multiple mechanisms of MYCN dysregulation in Wilms tumour
Williams, R. D., Chagtai, T., Alcaide-German, M., Apps, J. R., Wegert, J., Popov, S., Vujanic, G. M., van Tinteren, H., van den Heuvel‐Eibrink, M. M., Kool, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3377 · Cited by 102
Self-citationMeningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications
Bi, W. L., Zhang, M., Wu, W. W., Mei, Y., & Dunn, I. F. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00040 · Cited by 106
Ichimura, K., Fukushima, S., Totoki, Y., Matsushita, Y., Otsuka, A., Tomiyama, A., Niwa, T., Takami, H., Nakamura, T., Suzuki, T., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1557-x · Cited by 79
Cancer genome-sequencing study design
Mwenifumbo, J. C., & Marra, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3445 · Cited by 104
Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma
Goschzik, T., Gessi, M., Dreschmann, V., Gebhardt, U., Wang, L., Yamaguchi, S., Wheeler, D. A., Lauriola, L., Lau, C. C., Muller, H. L., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw116 · Cited by 101
Medulloblastoma: Molecular Classification-Based Personal Therapeutics
Archer, T. C., Mahoney, E. L., & Pomeroy, S. L. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0526-y · Cited by 107
Self-citationGarieri, M., Stamoulis, G., Blanc, X., Falconnet, E., Ribaux, P., Borel, C., Santoni, F. A., & Antonarakis, S. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806811115 · Cited by 96
Tiberi, L., Bonnefont, J., van den Ameele, J., Bon, S. D. L., Herpoel, A., Bilheu, A., Baron, B. W., & Vanderhaeghen, P. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.021 · Cited by 101
Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways
Guo, C., Chang, C.-C., Wortham, M., Chen, L. H., Kernagis, D., Qin, X., Cho, Y., Chi, J., Grant, G. A., McLendon, R. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208807109 · Cited by 101
Self-citationFloor, S. N., Condon, K. J., Sharma, D., Jankowsky, E., & Doudna, J. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700625 · Cited by 97
Obstacles to Brain Tumor Therapy: Key ABC Transporters
Wijaya, J., Fukuda, Y., & Schuetz, J. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122544 · Cited by 101
Thatikonda, V., Islam, S. M. A., Autry, R. J., Jones, B. C., Gröbner, S. N., Warsow, G., Hutter, B., Hüebschmann, D., Fröhling, S., Kool, M., et al. (2023) · Nature Cancer · doi:10.1038/s43018-022-00509-4 · Cited by 100
Self-citationChromatin and oxygen sensing in the context of JmjC histone demethylases
Shmakova, A., Batie, M., Druker, J., & Rocha, S. (2014) · Biochemical Journal · doi:10.1042/bj20140754 · Cited by 99
Understanding genomic alterations in cancer genomes using an integrative network approach
Wang, E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.050 · Cited by 100
Recent developments and current concepts in medulloblastoma
Gerber, N. U., Mynarek, M., von Hoff, K., Friedrich, C., Resch, A., & Rutkowski, S. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.010 · Cited by 98
Self-citationNew drugs for children and adolescents with cancer: the need for novel development pathways
Vassal, G., Zwaan, C. M., Ashley, D. M., Deley, M. L., Hargrave, D. R., Blanc, P., & Adamson, P. C. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70013-5 · Cited by 101
BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation
Zhu, D., Osuka, S., Zhang, Z., Reichert, Z. R., Yang, L., Kanemura, Y., Jiang, Y., You, S., Zhang, H., Devi, N. S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.006 · Cited by 96
Ku, C., & Roukos, D. H. (2013) · Expert Review of Medical Devices · doi:10.1586/erd.12.63 · Cited by 95
Intellectual Outcome in Molecular Subgroups of Medulloblastoma
Moxon‐Emre, I., Taylor, M. D., Bouffet, É., Hardy, K. K., Campen, C. J., Malkin, D. M., Hawkins, C. E., Laperrière, N., Ramaswamy, V., Bartels, U. K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9077 · Cited by 94
Self-citationTwigg, S. R. F., Hufnagel, R. B., Miller, K. A., Zhou, Y., McGowan, S. J., Taylor, J., Craft, J., Taylor, J. C., Santoro, S. L., Huang, T., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.04.007 · Cited by 93
Holdhof, D., Johann, P. D., Spohn, M., Bockmayr, M. L., Safaei, S., Joshi, P. K., Masliah‐Planchon, J., Ho, B., Andrianteranagna, M. J. D. D., Bourdeaut, F., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02250-7 · Cited by 93
Self-citationFontebasso, A. M., Liu, X., Sturm, D., & Jabado, N. (2013) · Brain Pathology · doi:10.1111/bpa.12023 · Cited by 89
Self-citationTargeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Ecker, J., Oehme, I., Mazitschek, R., Korshunov, A., Kool, M., Hielscher, T., Kiss, J., Selt, F., Konrad, C., Lodrini, M., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0201-7 · Cited by 92
Self-citationDefective homologous recombination DNA repair as therapeutic target in advanced chordoma
Gröschel, S., Hübschmann, D., Raimondi, F., Horak, P., Warsow, G., Fröhlich, M., Klink, B., Gieldon, L., Hutter, B., Kleinheinz, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09633-9 · Cited by 92
Self-citationGong, C., Krupka, J. A., Gao, J., Grigoropoulos, N. F., Giotopoulos, G., Asby, R. J., Screen, M., Usheva, Z., Cucco, F., Barrans, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2021.07.041 · Cited by 86
Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells
Trejo‐Solís, C., Escamilla-Ramírez, Á., Jiménez‐Farfán, D., Castillo‐Rodríguez, R. A., Flores‐Nájera, A., & Cruz-Salgado, A. (2021) · Pharmaceuticals · doi:10.3390/ph14090871 · Cited by 95
Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions
Betts, M. J., Lu, Q., Jiang, Y., Drusko, A., Wichmann, O., Utz, M., Valtierra-Gutiérrez, I. A., Schlesner, M., Jäger, N., Jones, D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1094 · Cited by 90
Self-citationHypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer
Jäger, N., Schlesner, M., Jones, D. T. W., Raffel, S., Mallm, J.-P., Junge, K. M., Weichenhan, D., Bauer, T., Ishaque, N., Kool, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.042 · Cited by 90
Self-citationHuman PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors
Henssen, A. G., Koche, R. P., Zhuang, J., Jiang, E., Reed, C., Eisenberg, A., Still, E., MacArthur, I. C., Rodríguez-Fos, E., González, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3866 · Cited by 89
Integrated molecular characterization of IDH ‐mutant glioblastomas
Korshunov, A., Casalini, B., Chávez, L., Hielscher, T., Sill, M., Ryzhova, M. V., Sharma, T. S., Schrimpf, D., Stichel, D., Capper, D., et al. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12523 · Cited by 93
Self-citationACVR1 Mutations in DIPG: Lessons Learned from FOP
Taylor, K. R., Vinci, M., Bullock, A. N., & Jones, C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1298 · Cited by 95
OTP: An automatized system for managing and processing NGS data.
Reisinger, E., Genthner, L., Kerssemakers, J. N. A., Kensche, P. R., Borufka, S., Jugold, A., Kling, A., Prinz, M., Scholz, I., Zipprich, G., et al. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.08.006 · Cited by 72
Self-citationAdvances in the molecular classification of pediatric brain tumors: a guide to the galaxy
Cacciotti, C., Fleming, A. J., & Ramaswamy, V. (2020) · The Journal of Pathology · doi:10.1002/path.5457 · Cited by 92
Cancer-Associated Mutants of RNA Helicase DDX3X Are Defective in RNA-Stimulated ATP Hydrolysis
Epling, L. B., Grace, C. R., Lowe, B. R., Partridge, J. F., & Enemark, E. J. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.015 · Cited by 87
Children's Oncology Group's 2013 blueprint for research: Central nervous system tumors
Gajjar, A. J., Packer, R. J., Foreman, N. K., Cohen, K. J., Haas-Kogan, D. A., & Merchant, T. E. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24427 · Cited by 87
Pagès, M., Rotem, D., Gydush, G., Reed, S. C., Rhoades, J., Ha, G., Lo, C., Fleharty, M., Duran, M., Jones, R. E., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noab299 · Cited by 90
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer
van Voss, M. R. H., Vesuna, F., Trumpi, K., Brilliant, J., Berlinicke, C. A., de Leng, W. W. J., Kranenburg, O., Offerhaus, G. J. A., Buerger, H., van der Wall, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4873 · Cited by 84
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
Ratnaparkhe, M., Wong, J., Wei, P., Hlevnjak, M., Kolb, T., Simovic-Lorenz, M., Haag, D., Paul, Y., Devens, F., Northcott, P. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06925-4 · Cited by 84
Self-citationSin‐Chan, P., Mumal, I., Suwal, T., Ho, B., Fan, X., Singh, I., Du, Y., Lu, M., Patel, N., Torchia, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.002 · Cited by 84
Self-citationYang, Z., Jones, A., Widschwendter, M., & Teschendorff, A. E. (2015) · Genome biology · doi:10.1186/s13059-015-0699-9 · Cited by 83
The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases
Romero, O. A., & Sánchez‐Céspedes, M. (2013) · Oncogene · doi:10.1038/onc.2013.227 · Cited by 85
Chromatin-Remodeling-Factor ARID1B Represses Wnt/β-Catenin Signaling
Vasileiou, G., Ekici, A. B., Uebe, S., Zweier, C., Hoyer, J., Engels, H., Behrens, J., Reis, A., & Hadjihannas, M. V. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.08.002 · Cited by 81
Zhang, Z., Teng, X., Zhao, F. Q., Ma, C., Zhang, J., Xiao, L.-F., Wang, Y., Chang, M., Tian, Y., Li, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111530 · Cited by 81
Targeted inactivation of murineDdx3x: essential roles ofDdx3xin placentation and embryogenesis
Chen, C.-Y., Chan, C.-H., Chen, C., Tsai, Y.-S., Tsai, T.-Y., Lee, Y. W., & You, L. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw143 · Cited by 79
Metadata
- Authors
- Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., Rausch, T., Warnatz, H.-J., Ryzhova, M., Bender, S., Sturm, D., Pleier, S., Cin, H., Pfaff, E., Sieber, L., Wittmann, A., Remke, M., Witt, H., Hutter, S., Tzaridis, T., Weischenfeldt, J., Raeder, B., Avci, M., Amstislavskiy, V., Zapatka, M., Weber, U. D., Wang, Q., Lasitschka, B., Bartholomae, C. C., Schmidt, M., von Kalle, C., Ast, V., Lawerenz, C., Eils, J., Kabbe, R., Benes, V., van Sluis, P., Koster, J., Volckmann, R., Shih, D., Betts, M. J., Russell, R. B., Coco, S., Paolo Tonini, G., Schüller, U., Hans, V., Graf, N., Kim, Y.-J., Monoranu, C., Roggendorf, W., Unterberg, A., Herold-Mende, C., Milde, T., Kulozik, A. E., von Deimling, A., Witt, O., Maass, E., Rössler, J., Ebinger, M., Schuhmann, M. U., Frühwald, M. C., Hasselblatt, M., Jabado, N., Rutkowski, S., von Bueren, A. O., Williamson, D., Clifford, S. C., McCabe, M. G., Peter Collins, V., Wolf, S., Wiemann, S., Lehrach, H., Brors, B., Scheurlen, W., Felsberg, J., Reifenberger, G., Northcott, P. A., Taylor, M. D., Meyerson, M., Pomeroy, S. L., Yaspo, M.-L., Korbel, J. O., Korshunov, A., Eils, R., Pfister, S. M., & Lichter, P.
- Affiliations
- German Cancer Research Center (DE)
- European Molecular Biology Laboratory (DE)
- Max Planck Institute for Molecular Genetics (DE)
- Stanford University (US)
- Broad Institute (US)
- Burdenko Neurosurgery Institute (RU)
- Amsterdam UMC Location University of Amsterdam (NL)
- Hospital for Sick Children (CA)
- Heidelberg University (DE)
- Ospedale Policlinico San Martino (IT)
- Institut für Neuropathologie (DE)
- Evangelisches Krankenhaus Bielefeld (DE)
- Universitätsklinikum des Saarlandes (DE)
- University of Würzburg (DE)
- University Hospital Heidelberg (DE)
- Olgahospital (DE)
- University Medical Center Freiburg (DE)
- University Children's Hospital Tübingen (DE)
- University Hospital Münster (DE)
- McGill University Health Centre (CA)
- University Medical Center Hamburg-Eppendorf (DE)
- Royal Victoria Infirmary (GB)
- University of Cambridge (GB)
- Cnopf´sche Kinderklinik (DE)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Eils, Roland
- Pfister, Stefan M.
- Lichter, Peter
- ORCID
- Jones, David T. W.
- Jäger, Natalie
- Kool, Marcel
- Zichner, Thomas
- Hutter, Barbara
- Sultan, Marc
- Cho, Yoon-Jae
- Pugh, Trevor J.
- Hovestadt, Volker
- Stütz, Adrian M.
- Rausch, Tobias
- Warnatz, Hans-Jörg
- Ryzhova, Marina
- Sturm, Dominik
- Pfaff, Elke
- Remke, Marc
- Witt, Hendrik
- Hutter, Sonja
- Tzaridis, Theophilos
- Weischenfeldt, Joachim
- Raeder, Benjamin
- Amstislavskiy, Vyacheslav
- Zapatka, Marc
- Wang, Qi
- Schmidt, Manfred
- Ast, Volker
- Kabbe, Rolf
- Volckmann, Richard
- Shih, David
- Betts, Matthew J.
- Russell, Robert B.
- Coco, Simona
- Schüller, Ulrich
- Graf, Norbert
- Kim, Yoo-Jin
- Unterberg, Andreas
- Milde, Till
- Kulozik, Andreas E.
- Witt, Olaf
- Rössler, Jochen
- Ebinger, Martin
- Schuhmann, Martin U.
- Frühwald, Michael C.
- Hasselblatt, Martin
- Jabado, Nada
- Rutkowski, Stefan
- Clifford, Steven C.
- McCabe, Martin G.
- Wiemann, Stefan
- Brors, Benedikt
- Felsberg, Jörg
- Reifenberger, Guido
- Northcott, Paul A.
- Taylor, Michael D.
- Meyerson, Matthew
- Pomeroy, Scott L.
- Yaspo, Marie-Laure
- Korbel, Jan O.
- Korshunov, Andrey
- Eils, Roland
- Pfister, Stefan M.
- Lichter, Peter
- Venue
- Nature
- Published
- 2012-07-25
- Volume
- 488
- Issue
- 7409
- Pages
- 100-105
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3662966
- OpenAlex
- W2167532631
- Cited by
- 839
- References
- 27
- Citations by year
- 2026: 8 · 2025: 31 · 2024: 28 · 2023: 41 · 2022: 42 · 2021: 60 · 2020: 51 · 2019: 49 · 2018: 69 · 2017: 73 · 2016: 86 · 2015: 81 · 2014: 89 · 2013: 102 · 2012: 28
- FWCI
- 45.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by-nc-sa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Pediatric Brain Tumor Foundation
- Deutsches Krebsforschungszentrum
- Children's Cancer and Leukaemia Group
- Cancer Research UK (13457)
- Brain Tumour Charity (16/92, 10/106)
- Bundesministerium für Bildung und Forschung (01GS0883)
- Hungarian Scientific Research Fund
- Max-Planck-Gesellschaft
- Deutsche Krebshilfe (109252)
- Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft
- National Cancer Institute (R01CA109467)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- medulloblastoma, Group 3 medulloblastoma, Group 4 medulloblastoma, tetraploidy, somatic copy number alterations, TGF-beta signaling, NF-κB signaling, recurrent mutations, pediatric brain tumors, tumor heterogeneity
- MeSH terms
- Patched Receptors, Patched-1 Receptor, Aging, Amino Acid Sequence, Cell Transformation, Neoplastic, Cerebellar Neoplasms, Child, Chromatin, Chromosomes, Human, DNA Helicases, DNA-Binding Proteins, Humans, Medulloblastoma, Methylation, Mutation, Neoplasm Proteins, Nuclear Proteins, Phosphoprotein Phosphatases, Polyploidy, Receptors, Cell Surface, Transcription Factors, Signal Transduction, Oncogene Proteins, Fusion, Genome, Human, Sequence Analysis, RNA, T-Box Domain Proteins, Genomics, Wnt Proteins, beta Catenin, DEAD-box RNA Helicases, Hedgehog Proteins, Histone Demethylases, High-Throughput Nucleotide Sequencing, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
